申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0187390A2
公开(公告)日:1986-07-16
57 This invention relates to novel β-methylene- thiophenethanamines which are mechanism-based inhibitors of dopamine beta-hydroxylase useful as antihypertensive agents.
57 本发明涉及新型β-亚甲基
噻吩乙胺,它是
多巴胺β-羟化酶的机理
抑制剂,可用作降压药。